Drug Type Small molecule drug |
Synonyms Glycolipid di-rhamnolipid C10-C10 |
Target |
Mechanism CD1d inhibitors(CD1d antigens inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | US | 26 Jul 2023 | |
Inflammation | Preclinical | US | 26 Jul 2023 | |
Metabolic Syndrome | Preclinical | US | 26 Jul 2023 | |
Nonalcoholic Steatohepatitis | Preclinical | US | 26 Jul 2023 |